These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17450761)

  • 1. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
    McCann LJ; Woo P
    Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatments for juvenile idiopathic arthritis.
    Hashkes PJ; Friedland O; Uziel Y
    Isr Med Assoc J; 2002 Jan; 4(1):39-43. PubMed ID: 11802310
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
    Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 6. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S; Liebert UG; Borte M; Sack U
    Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced therapy for juvenile arthritis.
    Murray KJ; Lovell DJ
    Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):361-78. PubMed ID: 12387805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of etanercept in children.
    Wargula JC; Lovell DJ
    Bull Rheum Dis; 2000; 49(12):1-4. PubMed ID: 11314579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
    de Inocencio Arocena J; Merino Muñoz R; Alvarez Madrid C; García-Consuegra Molina J
    An Pediatr (Barc); 2009 Apr; 70(4):354-61. PubMed ID: 19324597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
    Prince FH; Twilt M; Simon SC; van Rossum MA; Armbrust W; Hoppenreijs EP; Kamphuis S; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; ten Cate R; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 Jul; 68(7):1228-9. PubMed ID: 19525408
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis.
    Remesal A; DE Inocencio J; Merino R; Garcia-Consuegra J
    J Rheumatol; 2010 Sep; 37(9):1970-1. PubMed ID: 20810527
    [No Abstract]   [Full Text] [Related]  

  • 15. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapy for early rheumatoid arthritis: the latest evidence.
    Castro-Rueda H; Kavanaugh A
    Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G; Ebert A; Fitter S; Minden K; Foeldvari I; Kümmerle-Deschner J; Thon A; Girschick HJ; Weller F; Huppertz HI
    Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
    Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
    Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on treatment of arthritis in children: new treatments, new goals.
    Lovell DJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of juvenile idiopathic arthritis].
    Kröger L; Vähäsalo P; Tynjälä P; Aalto K; Säilä H; Malin M; Putto-Laurila A; Lahdenne P
    Duodecim; 2012; 128(5):477-86. PubMed ID: 22486063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.